ClinicalTrials.Veeva

Menu

Comparison of the Effects of an Hypertonic Solution With Ringer Lactate on Right Ventricular Function Following Cardiac Surgery (SUCCESS)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status and phase

Completed
Phase 3

Conditions

Right Ventricular Impaired Function
Hypovolemia

Treatments

Drug: Ringer Lactate (10ml/kg) fluid expansion
Drug: Hypertonic saline (3ml/kg) fluid expansion

Study type

Interventional

Funder types

Other

Identifiers

NCT02782520
38RC15.214

Details and patient eligibility

About

This study is a phase III, randomized, controled, parallel groups, single blinded, clinical trial that aims at comparing the improvement of right ventricular function after administration of a hypertonic solution versus Ringer Lactate following cardiac surgery.

Adults patients admitted to Grenoble University Hospital for elective cardiac surgery under cardiopulmonary bypass, in sinus rhythm and with Swan Ganz monitoring will be included.

Patients needing fluid expansion in the first three hours after surgery will be randomized in two groups : one receiving Ringer Lactate (10 mL/kg), the other receiving hypertonic saline solution (3 mL/kg).

Right ventricular function measured with Swan Ganz catheter, 30 minutes after fluid expansion will be the primary outcome.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Elective valvular or coronary surgery
  • Under cardiopulmonary bypass
  • Patient requiring Swan Ganz catheter monitoring
  • Patient in sinus rhythm
  • Patient requiring post-operative volemic expansion
  • Echographic criteria of hypovolemia, without hypervolemia

Exclusion criteria

  • Pulmonary hypertension (SPAP > 60mmHg)
  • No pre-operative sinus rhythm
  • Emergency surgery
  • Age < 18 years
  • Chronic renal failure treated with dialysis
  • Severe hypernatremia

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

Ringer Lactate
Active Comparator group
Description:
Ringer Lactate group
Treatment:
Drug: Ringer Lactate (10ml/kg) fluid expansion
Hypertonic saline
Experimental group
Description:
Hypertonic saline group
Treatment:
Drug: Hypertonic saline (3ml/kg) fluid expansion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems